341 related articles for article (PubMed ID: 19466903)
61. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone.
Shinagawa K; Shiroshita-Takeshita A; Schram G; Nattel S
Circulation; 2003 Mar; 107(10):1440-6. PubMed ID: 12642367
[TBL] [Abstract][Full Text] [Related]
62. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
Lévy S
Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
[TBL] [Abstract][Full Text] [Related]
63. RSD-1235. Cardiome.
Billman GE
Curr Opin Investig Drugs; 2003 Mar; 4(3):352-4. PubMed ID: 12735238
[TBL] [Abstract][Full Text] [Related]
64. In silico study on the effects of IKur block kinetics on prolongation of human action potential after atrial fibrillation-induced electrical remodeling.
Tsujimae K; Murakami S; Kurachi Y
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H793-800. PubMed ID: 18055524
[TBL] [Abstract][Full Text] [Related]
65. Chronic B-Type Natriuretic Peptide Therapy Prevents Atrial Electrical Remodeling in a Rabbit Model of Atrial Fibrillation.
Zhao H; Li T; Liu G; Zhang L; Li G; Yu J; Lou Q; He R; Zhan C; Li L; Yang W; Zang Y; Cheng C; Li W
J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):575-585. PubMed ID: 31159577
[TBL] [Abstract][Full Text] [Related]
66. Potential application of late sodium current blockade in the treatment of heart failure and atrial fibrillation.
Doshi D; Morrow JP
Rev Cardiovasc Med; 2009; 10 Suppl 1():S46-52. PubMed ID: 19898288
[TBL] [Abstract][Full Text] [Related]
67. Antiarrhythmic therapy in atrial fibrillation.
Ravens U
Pharmacol Ther; 2010 Oct; 128(1):129-45. PubMed ID: 20624425
[TBL] [Abstract][Full Text] [Related]
68. New pharmacological targets and treatments for atrial fibrillation.
Carlsson L; Duker G; Jacobson I
Trends Pharmacol Sci; 2010 Aug; 31(8):364-71. PubMed ID: 20605645
[TBL] [Abstract][Full Text] [Related]
69. Class 1 antiarrhythmic agents for therapy of atrial fibrillation.
Podrid PJ
Herz; 1993 Feb; 18(1):9-19. PubMed ID: 8454255
[TBL] [Abstract][Full Text] [Related]
70. Atrial fibrillation and renin-angiotensin system.
Serra JL; Bendersky M
Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
[TBL] [Abstract][Full Text] [Related]
71. Smoothing the Bumpy Road to Antiarrhythmic Drug Development.
Robinson VM; Kowey PR
Circulation; 2015 Dec; 132(23):2195-7. PubMed ID: 26499961
[No Abstract] [Full Text] [Related]
72. Analysis of electropharmacological effects of AVE0118 on the atria of chronic atrioventricular block dogs: characterization of anti-atrial fibrillatory action by atrial repolarization-delaying agent.
Kambayashi R; Hagiwara-Nagasawa M; Ichikawa T; Goto A; Chiba K; Nunoi Y; Izumi-Nakaseko H; Matsumoto A; Takahara A; Sugiyama A
Heart Vessels; 2020 Sep; 35(9):1316-1322. PubMed ID: 32346771
[TBL] [Abstract][Full Text] [Related]
73. Perspectives and challenges of antioxidant therapy for atrial fibrillation.
Gasparova I; Kubatka P; Opatrilova R; Caprnda M; Filipova S; Rodrigo L; Malan L; Mozos I; Rabajdova M; Nosal V; Kobyliak N; Valentova V; Petrovic D; Adamek M; Kruzliak P
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):1-14. PubMed ID: 27900409
[TBL] [Abstract][Full Text] [Related]
74. Evaluation of KCB-328, a new IKr blocking antiarrhythmic agent in pacing induced canine atrial fibrillation.
Chandra P; Rosen TS; Yeom ZH; Lee K; Kim HY; Danilo P; Rosen MR
Europace; 2004 Sep; 6(5):384-91. PubMed ID: 15294262
[TBL] [Abstract][Full Text] [Related]
75. Depolarization of the atrial resting membrane potential as an approach to enhance the anti-atrial fibrillation efficacy of sodium channel blockers.
Burashnikov A
Heart Rhythm; 2021 Jul; 18(7):1221-1222. PubMed ID: 33785461
[No Abstract] [Full Text] [Related]
76. Atrial selectivity of antiarrhythmic drugs.
Ravens U; Poulet C; Wettwer E; Knaut M
J Physiol; 2013 Sep; 591(17):4087-97. PubMed ID: 23732646
[TBL] [Abstract][Full Text] [Related]
77. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.
Burstein B; Nattel S
J Am Coll Cardiol; 2008 Feb; 51(8):802-9. PubMed ID: 18294563
[TBL] [Abstract][Full Text] [Related]
78. Atrial remodeling and novel pharmacological strategies for antiarrhythmic therapy in atrial fibrillation.
Jost N; Kohajda Z; Kristóf A; Kovács PP; Husti Z; Juhász V; Kiss L; Varró A; Virág L; Baczkó I
Curr Med Chem; 2011; 18(24):3675-94. PubMed ID: 21774760
[TBL] [Abstract][Full Text] [Related]
79. Ion channel trafficking: a new therapeutic horizon for atrial fibrillation.
Schumacher SM; Martens JR
Heart Rhythm; 2010 Sep; 7(9):1309-15. PubMed ID: 20156596
[TBL] [Abstract][Full Text] [Related]
80. Remodelling in atrial fibrillation: the impact of amiodarone.
Grosu AI; Radulescu D; Grosu LC; Pop D
Cardiovasc J Afr; 2019 May/Jun 23; 30(3):174-180. PubMed ID: 31140543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
